Literature DB >> 21512404

Epidermal growth factor receptor mutation status in stage I lung adenocarcinoma with different image patterns.

Kuo-Hsuan Hsu1, Kun-Chieh Chen, Tsung-Ying Yang, Yi-Chen Yeh, Teh-Ying Chou, Hsuan-Yu Chen, Chi-Ren Tsai, Chih-Yi Chen, Chung-Ping Hsu, Jiun-Yi Hsia, Cheng-Yen Chuang, Ying-Huang Tsai, Kuan-Yu Chen, Ming-Shyan Huang, Wu-Chou Su, Yuh-Min Chen, Chao A Hsiung, Gee-Chen Chang, Chien-Jen Chen, Pan-Chyr Yang.   

Abstract

PURPOSE: Early lung adenocarcinoma may present with ground-glass opacity (GGO) component in computed tomography (CT) scan. Epidermal growth factor receptor (EGFR) mutation had been reported in patients with lung cancer with GGO patterns. Nevertheless, the correlation between clinical characteristics, CT image patterns, and EGFR mutation status was indeterminate.
METHODS: Patients with stage I lung adenocarcinoma with tumor lesions less than 3 cm were included and classified into pure GGO, part-solid, and solid patterns by CT scan images. All patients had EGFR mutation test from frozen tumors. Available paraffin-embedded archival tissues were microdissected into three different locations similar to CT images with central and peripheral parts of tumor, and adjacent normal part for EGFR mutation tests.
RESULTS: Totally, 162 patients were analyzed, 90 women and 72 men, and 128 nonsmokers. The patients included 35 (21.6%) pure GGO, 41 (25.3%) part-solid, and 86 (53.1%) solid lesions. The EGFR mutation rate was 64.2% (n = 104). Analysis of the correlation between CT image patterns and EGFR mutation, the less GGO ratio had more typical mutation, especially L858R (p = 0.037). In 45 microdissected tumors, the central and peripheral parts had the same EGFR mutation status. In adjacent normal parts, 5 of 32 (15.6%) EGFR mutant patients had identical mutation but none in nonmutant patients.
CONCLUSIONS: In stage I lung adenocarcinoma, typical mutation, especially L858R was detected more frequent in invasive solid pattern and significantly less in pure GGO pattern. EGFR mutation is an early event in the pathogenesis of lung adenocarcinoma and may facilitate the tumor into aggressive behavior.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21512404     DOI: 10.1097/JTO.0b013e31821667b0

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


  27 in total

1.  Large-Scale EGFR Mutation Testing in Clinical Practice: Analysis of a Series of 18,920 Non-Small Cell Lung Cancer Cases.

Authors:  Matthew Evans; Brendan O'Sullivan; Matthew Smith; Frances Hughes; Tina Mullis; Nicola Trim; Philippe Taniere
Journal:  Pathol Oncol Res       Date:  2018-08-09       Impact factor: 3.201

2.  Prognostic value and molecular correlates of a CT image-based quantitative pleural contact index in early stage NSCLC.

Authors:  Juheon Lee; Yi Cui; Xiaoli Sun; Bailiang Li; Jia Wu; Dengwang Li; Michael F Gensheimer; Billy W Loo; Maximilian Diehn; Ruijiang Li
Journal:  Eur Radiol       Date:  2017-08-07       Impact factor: 5.315

3.  Correlation in histological subtypes with high resolution computed tomography signatures of early stage lung adenocarcinoma.

Authors:  Yingying Miao; Jianya Zhang; Jiawei Zou; Qingqing Zhu; Tangfeng Lv; Yong Song
Journal:  Transl Lung Cancer Res       Date:  2017-02

Review 4.  Pulmonary ground-glass opacity: computed tomography features, histopathology and molecular pathology.

Authors:  Jian-Wei Gao; Stefania Rizzo; Li-Hong Ma; Xiang-Yu Qiu; Arne Warth; Nobuhiko Seki; Mizue Hasegawa; Jia-Wei Zou; Qian Li; Marco Femia; Tang-Feng Lv; Yong Song
Journal:  Transl Lung Cancer Res       Date:  2017-02

5.  Impact of the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification of stage IA adenocarcinoma of the lung: Correlation between computed tomography images and EGFR and KRAS gene mutations.

Authors:  Tengteng Wang; Tao Zhang; Xiaoxue Han; X I Liu; Naikang Zhou; Yang Liu
Journal:  Exp Ther Med       Date:  2015-04-14       Impact factor: 2.447

Review 6.  Clinical and Radiological Characteristics to Differentiate Between EGFR Exon 21 and Exon 19 Mutations in Patients With Lung Adenocarcinoma: A Systematic Literature Review and Meta-Analysis.

Authors:  Andrés Felipe Herrera Ortiz; Mateo E Garland; Bassel Almarie
Journal:  Cureus       Date:  2022-05-29

7.  CT Features Associated with Epidermal Growth Factor Receptor Mutation Status in Patients with Lung Adenocarcinoma.

Authors:  Ying Liu; Jongphil Kim; Fangyuan Qu; Shichang Liu; Hua Wang; Yoganand Balagurunathan; Zhaoxiang Ye; Robert J Gillies
Journal:  Radiology       Date:  2016-03-03       Impact factor: 11.105

8.  Predicting EGFR mutation status in lung cancer:Proposal for a scoring model using imaging and demographic characteristics.

Authors:  Ali Sabri; Madiha Batool; Zhaolin Xu; Drew Bethune; Mohamed Abdolell; Daria Manos
Journal:  Eur Radiol       Date:  2016-03-30       Impact factor: 5.315

9.  Clinical Features and Gene Mutations of Lung Cancer Patients 30 Years of Age or Younger.

Authors:  Yuehong Wang; Junjun Chen; Wei Ding; Bing Yan; Qiqi Gao; Jianying Zhou
Journal:  PLoS One       Date:  2015-09-02       Impact factor: 3.240

10.  Epidermal growth factor receptor mutations and anaplastic lymphoma kinase rearrangements in lung cancer with nodular ground-glass opacity.

Authors:  Sung-Jun Ko; Yeon Joo Lee; Jong Sun Park; Young-Jae Cho; Ho Il Yoon; Jin-Haeng Chung; Tae Jung Kim; Kyung Won Lee; Kwhanmien Kim; Sanghoon Jheon; Hyojin Kim; Jae Ho Lee; Choon-Taek Lee
Journal:  BMC Cancer       Date:  2014-05-03       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.